ACSL4 and neoplasm: This platform ind uces immunogenic ferroptosis—a form of programmed cell death—while upregulating AA expression to enhance ACSL4-mediated tumor cell death, synergizing with CD8+ T cell-derived IFN-γ to boost anti-tumor immunity 45.